Relevant bibliographies by topics / 517.977.14: 620.1

Contents

  1. Journal articles
  2. Book chapters
  3. Conference papers
  4. Reports

Academic literature on the topic '517.977.14: 620.1'

Author: Grafiati
Published: 30 May 2022
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '517.977.14: 620.1.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "517.977.14: 620.1"

1

Pinzón Ardila, Omar. "Modelado de un Recuperador Dinámico de Tensión para el Mejoramiento de la Calidad de la Onda de Tensión." BISTUA REVISTA DE LA FACULTAD DE CIENCIAS BASICAS 14, no. 1 (2016): 62. http://dx.doi.org/10.24054/01204211.v1.n1.2016.1938.

Full text
Abstract:
[1] R. C. Dugan, H. W. Beaty, y S. Santoso, Electrical Power Systems Quality, Third edition. Tata McGraw Hill Education, 2012.[2] J. Arrilaga y N. R. Watson, Power System Harmonics. Jhon Wiley and Sons, 2003.[3] H. Kim, F. Blaabjerg, B. Bak-Jensen, y J. Choi, «Instantaneous power compensation in three-phase systems by using p-q-r theory», en Power Electronics Specialists Conference, 2001. PESC. 2001 IEEE 32nd Annual, 2001, vol. 2, pp. 478–485 vol.2.[4] J. G. Nielsen y F. Blaabjerg, «Comparison of system topologies for dynamic voltage restorers», en Conference Record of the 2001 IEEE Industry A
APA, Harvard, Vancouver, ISO, and other styles
2

Su, Wu-Chou, Ming Huang Chen, Li-Yuan Bai, et al. "CVM-1118: A potent oral anti-vasculogenic mimicry (VM) agent in patients with advanced neuroendocrine tumors (NETs)—A phase IIa study." Journal of Clinical Oncology 41, no. 16_suppl (2023): e16235-e16235. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e16235.

Full text
Abstract:
e16235 Background: CVM-1118 is a potent anti-tumor new chemical entity with multiple mechanisms of action including induction of apoptosis, cell cycle arrest, and inhibition of VM network formation. The Phase I trial in Asia determined an MTD of 600 mg daily (300 mg BID) with a favorable safety profile. The best response was stable disease with measurable tumor reduction in one patient with NET. We present preliminary results for this ongoing Phase IIa study. Methods: Eligible patients had advanced NETs (low/intermediate grade lung or WHO grade 1 or 2 gastrointestinal or pancreatic origin) whi
APA, Harvard, Vancouver, ISO, and other styles
3

Hinton, Jason D., David P. Livingston, Grady L. Miller, Charles H. Peacock, and Tan Tuong. "Freeze Tolerance of Nine Zoysiagrass Cultivars Using Natural Cold Acclimation and Freeze Chambers." HortScience 47, no. 1 (2012): 112–15. http://dx.doi.org/10.21273/hortsci.47.1.112.

Full text
Abstract:
Winter-hardiness of zoysiagrass (Zoysia spp.) cultivars is an important attribute throughout the biogeographical transition zone; thus, the inability to withstand freezing temperatures may limit the use of these cultivars. The objective of this research was to determine the freeze tolerance (LT50) of nine zoysiagrass cultivars grown in Raleigh, NC. Four Zoysia japonica Steud. cultivars (JaMur, Palisades, Empire, and Ultimate) and five Zoysia matrella (L.) Merr. cultivars (Pristine, Zeon, Cavalier, Diamond, and Zorro) were chosen to undergo freeze testing. Cores were taken from the field in Feb
APA, Harvard, Vancouver, ISO, and other styles
4

Sepúlveda-Chavera, G., W. Huanca, R. Salvatierra-Martínez, and B. A. Latorre. "First Report of Fusarium oxysporum f. sp. lycopersici Race 3 and F. oxysporum f. sp. radicis-lycopersici in Tomatoes in the Azapa Valley of Chile." Plant Disease 98, no. 10 (2014): 1432. http://dx.doi.org/10.1094/pdis-03-14-0303-pdn.

Full text
Abstract:
Tomato (Solanum lycopersicum L.) is an important crop in the Azapa Valley (18°35′ S, 69°30′ W) in northern Chile, with approximately 600 ha of fresh tomatoes under greenhouses. Cultivars resistant to Fusarium oxysporum f. sp. lycopersici (FOL) races 1 and 2 are mainly used. However, in 2012 and 2013, Fusarium wilt incidence was 2 to 3%. Symptoms appeared unilaterally and consisted of yellowing, leaf wilting of lower leaves, dark brown vascular discoloration, and plant death. The aim of this study was to determine the causal agent of tomato wilt in seven tomato greenhouses in the Azapa Valley.
APA, Harvard, Vancouver, ISO, and other styles
5

Juul, Frederik E., Amanda J. Cross, Robert E. Schoen, et al. "Effectiveness of Colonoscopy Screening vs Sigmoidoscopy Screening in Colorectal Cancer." JAMA Network Open 7, no. 2 (2024): e240007. http://dx.doi.org/10.1001/jamanetworkopen.2024.0007.

Full text
Abstract:
ImportanceRandomized clinical screening trials have shown that sigmoidoscopy screening reduces colorectal cancer (CRC) incidence and mortality. Colonoscopy has largely replaced sigmoidoscopy for CRC screening, but long-term results from randomized trials on colonoscopy screening are still lacking.ObjectiveTo estimate the additional screening benefit of colonoscopy compared with sigmoidoscopy.Design, Setting, and ParticipantsThis comparative effectiveness simulation study pooled data on 358 204 men and women randomly assigned to sigmoidoscopy screening or usual care in 4 randomized sigmoidoscop
APA, Harvard, Vancouver, ISO, and other styles
6

Jestin, Matthieu, Sihem Tarfi, Bouchra Badaoui, et al. "The Absolute Count of Circulating, Classical, CD14++/CD16- Monocytes Is a Poor Prognosis Marker in Chronic Myelomonocytic Leukemia (CMML)." Blood 134, Supplement_1 (2019): 4242. http://dx.doi.org/10.1182/blood-2019-121794.

Full text
Abstract:
Introduction A relative increase in classical monocyte fraction (cMo, CD14++CD16-) over 94% of total peripheral blood monocytes, as measured by flow cytometry, distinguishes a CMML from a reactive monocytosis with a 94.1% specificity and a 92.8% sensitivity (Selimoglu-Buet, 2015; Talati, 2017; Patnaik, 2017; Selimoglu-Buet, 2017; Hudson, 2018). This phenotype is independent of the absolute monocyte count, WHO subtype of CMML, its dysplastic (MD) vs proliferative (MP) feature and its mutational background. The limitation of this diagnostic tool is the changes in monocyte subset repartition indu
APA, Harvard, Vancouver, ISO, and other styles
7

Heneghan, Mallorie B., Susan R. Rheingold, Yimei Li, et al. "Avascular Necrosis(AVN) and Surgical Intervention In Pediatric Acute Lymphoblastic Leukemia(ALL): A Retrospective Cohort Analysis From The Pediatric Health Information Systems (PHIS)." Blood 122, no. 21 (2013): 1689. http://dx.doi.org/10.1182/blood.v122.21.1689.1689.

Full text
Abstract:
Abstract Cure rates for acute lymphoblastic leukemia (ALL) have improved dramatically, but the incidence of avascular necrosis (AVN) has increased over the past decade. No national administrative data on the incidence of AVN or surgical therapies for AVN exist. We sought to define the incidence of AVN and AVN surgical interventions after treatment for ALL in a national administrative data set. The Pediatric Health Information System (PHIS) is an administrative database including ICD-9 discharge diagnosis, procedure codes, and billing data for daily resource utilization from 43 free standing pe
APA, Harvard, Vancouver, ISO, and other styles
8

Rogers, Kerry A., Qiuhong Zhao, Seema A. Bhat, et al. "Extended Follow up of a Phase 2 Study of Early Intervention with Lenalidomide in Patients with High-Risk Chronic Lymphocytic Leukemia." Blood 142, Supplement 1 (2023): 3272. http://dx.doi.org/10.1182/blood-2023-180308.

Full text
Abstract:
CONCLUSIONS Lenalidomide (LEN) is an effective therapy for chronic lymphocytic leukemia (CLL) and has immunomodulatory effects that were hypothesized to improve immune function in patients (pts) with untreated early stage CLL. A NCI/CTEP sponsored phase 2 study (NCT01351896) randomized asymptomatic pts with high-risk CLL to receive LEN either concurrent with or delayed from (3 months after 1st dose) two doses of 13-valent protein-conjugated pneumococcal vaccine (PCV13). The primary endpoint was the proportion of pts who achieve an antibody response to the 2nd PCV13 vaccine and was not signific
APA, Harvard, Vancouver, ISO, and other styles
9

Jabbour, Elias, Koji Sasaki, Mikkael A. Sekeres, et al. "Long-Term Outcome of Patients with Myelodysplastic Syndromes (MDS) Treated with Hypomethylating Agents (HMA): A Report on Behalf of the MDS Clinical Research Consortium." Blood 124, no. 21 (2014): 4641. http://dx.doi.org/10.1182/blood.v124.21.4641.4641.

Full text
Abstract:
Abstract Background: Therapy with HMA is now the standard of care for pts with MDS and chronic myelomonocytic leukemia (CMML) with complete response (CR) rates of 7% to 35%, median response durations of 9 to 10 months, and median survival of 20 to 24 months. While allogeneic stem cell transplantation (ASCT) is curative in pts with MDS, the long-term outcome of pts treated with HMA remains unknown. Aims: The aims of the study are to assess the long-term outcome of pts with MDS treated with HMA and to identify prognostic factors of long-term outcome. This may help selecting patients for this lon
APA, Harvard, Vancouver, ISO, and other styles
10

Majerczyk, Daniel, Erin M. Behnen, David J. Weldon, et al. "Racial, Ethnic, and Sex Diversity Trends in Health Professions Programs From Applicants to Graduates." JAMA Network Open 6, no. 12 (2023): e2347817. http://dx.doi.org/10.1001/jamanetworkopen.2023.47817.

Full text
Abstract:
ImportanceDiversity is an essential element of an effective health care system. A key to developing a diverse workforce is establishing a diverse student population in health professions programs.ObjectiveTo examine the diversity of students in Doctor of Medicine (MD), Doctor of Osteopathic Medicine (DO), Doctor of Dental Surgery (DDS), Doctor of Dental Medicine (DMD), and Doctor of Pharmacy (PharmD) programs with emphasis on the trends of underrepresented minoritized groups (American Indian or Alaska Native, Black or African American, Hispanic or Latino, and Native Hawaiian or Other Pacific I
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "517.977.14: 620.1"

1

Kenyon, Michelle, John Murray, Barry Quinn, Diana Greenfield, and Eugenia Trigoso. "Late Effects and Long-Term Follow-Up." In The European Blood and Marrow Transplantation Textbook for Nurses. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23394-4_15.

Full text
Abstract:
AbstractAllogeneic stem cell transplantation was successfully performed in 1968, and its use has grown significantly over the past five decades with the total number now exceeding 1.5 million patients (Niederwieser et al. Haematologica. 107:1045–1053, 2022). HSCT is a curative treatment for many haematological cancers and other disorders. Almost 40,000 HSCT procedures are performed Europe-wide per annum (Passweg et al. Bone Marrow Transplant. 51(6):786–92, 2016), and the number of transplant recipients achieving ‘long-term survival’ and with late effects directly related to their treatment (Ma
APA, Harvard, Vancouver, ISO, and other styles
2

Rigaudias, Cecilia Alvarez, and Alessandro Spina. "Article 38 Position of the data protection officer." In The EU General Data Protection Regulation (GDPR). Oxford University Press, 2020. http://dx.doi.org/10.1093/oso/9780198826491.003.0076.

Full text
Abstract:
Article 13(1)(b) (Information to be provided where personal data are collected from the data subject) (see too recitals 60–61); Article 14(1)(b) (Information to be provided where personal data have not been obtained from the data subject) (see too recital 61); Article 30 (Records of processing activities) (see too recital 82); Article 33 (Notification of a personal data breach to the supervisory authority) (see too recital 85); Article 35 (Data protection impact assessment) (see too recitals 90–91); Article 36 (Prior consultation) (see too recital 94); Article 37 (Designation of the Data Prote
APA, Harvard, Vancouver, ISO, and other styles
3

Ahluwalia, Gurvinder. "Development of the Scale of Spirituality for Workplaces." In Handbook of Research on Integrating Spirituality in Modern Workplaces. IGI Global, 2022. http://dx.doi.org/10.4018/978-1-6684-2533-6.ch008.

Full text
Abstract:
Spirituality is not a new area of research. The unavailability of standardized assessment measures of spirituality is the basis of the present investigation. Phase 1 of the present study developed themes through ‘self-report measurement' administered to 15 participants (G1) of different spiritual organizations and studying the glimpses of Indian spirituality. Results revealed 90 themes, which were used as variables for the development of the scale. Phase 2 involved the development of measures of spirituality for an adult sample. The author selected N=300 (G2) MCQ for Part-1 and Likert format f
APA, Harvard, Vancouver, ISO, and other styles
4

Cavalcanti, Ianê Augusto Muraro, Leonardo Oliveira de Souza, Lucas Henrique da Costa Cavalcanti, Raissa Oliveira de Azevedo, and Janaína dos Santos Dias. "Capítulo 2 – Meu corpo está se transformando Não sou mais menino Não sou mais menina." In Adole Saúde. Pontifícia Universidade Católica de São Paulo, 2025. https://doi.org/10.29327/5595655.1-2.

Full text
Abstract:
E aí, pessoal! Preparem-se para uma das fases mais incríveis da vida: a puberdade! Que faz parte da adolescência ou de forma carinhosa Adole. É como se o corpo de vocês passasse por uma reforma geral, sem aviso prévio, sabe? De repente, tudo muda, e é normal, é fisiológico. O legal é que todo mundo passa ou vai passar por isso! Vamos então aprender um pouco sobre essa fase tão importante da vida. A puberdade é tipo a ponte entre a infância e a adolescência. Seu corpo começa a se preparar para a vida adulta e para quem sabe um dia, construir sua família, ter filhos, ser um grande profissional.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "517.977.14: 620.1"

1

Медовщиков, В. В., Н. Б. Ешниязов, Э. Р. Хасанова та Ж. Д. Кобалава. "ВЫСОКАЯ ЧАСТОТА НАРУШЕНИЙ УГЛЕВОДНОГО ОБМЕНА СРЕДИ ГОСПИТАЛЬНЫХ ПАЦИЕНТОВ С СЕРДЕЧНО-СОСУДИСТЫМИ ЗАБОЛЕВАНИЯМИ". У X (XXIX) НАЦИОНАЛЬНЫЙ КОНГРЕСС ЭНДОКРИНОЛОГОВ с международным участием «Персонализированная медицина и практическое здравоохранение». ФГБУ «НМИЦ эндокринологии» Минздрава России, 2023. http://dx.doi.org/10.14341/cong23-26.05.23-267.

Full text
Abstract:
ЦЕЛЬ: оценить частоту впервые и ранее диагностированных нарушений углеводного обмена (НУО)
 среди пациентов, госпитализированных с сердечно-сосудистыми заболеваниями (ССЗ).
 МАТЕРИАЛЫ И МЕТОДЫ: в исследование было включено 773 пациента ≥40 лет с установленными ССЗ
 без сахарного диабета 1-го типа и других НУО за исключением ранее диагностированных сахарного диабета 2-го типа (СД2) и предиабета. В период с 01.06.2018 по 01.03.2020гг. в исследование были включены
 пациенты, госпитализированные с острым коронарным синдромом (ОКС) – 275 человек (35,6%), острой
 декомпенсац
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "517.977.14: 620.1"

1

การสังเคราะห์งานวิจัยทางการศึกษาด้วยการวิเคราะห์อภิมาน และการวิเคราะห์เนื้อหา : รายงานการวิจัย. สำนักงานคณะกรรมการการศึกษาแห่งชาติ, 1998. https://doi.org/10.58837/chula.res.1998.7.

Full text
Abstract:
การวิจัยครั้งนี้มีวัตถุประสงค์เพื่อสังเคราะห์รายงานการวิจัยทางการศึกษาและที่เกี่ยวข้องกัยการศึกษา จำนวน 323 เรื่องที่เสนอในการประชุมทางวิชาการครั้งที่ 9 ของสำนักงานคณะกรรมการการศึกษาแห่งชาติ การสังเคราะห์งานวิจัยครั้งนี้ ประกอบด้วยการสังเคราะห์ด้วยการวิเคราะห์อภิมานงานวิจัยเชิงปริมาณที่ใช้แบบการวิจัยเชิงทดลอง แบบการวิจัยเชิงสหสัมพันธ์ และการเปรียบเทียบ จำนวน 144 เรื่อง และการสังเคราะห์งานวิจัยด้วยการวิเคราะห์เนื้อหางานวิจัยที่เป็นการวิจัยเชิงคุณลักษณะและการวิจัยแบบบรรยาย จำนวน 179 เรื่อง ในการวิเคราะห์อภิมานเป็นการเก็บรวบรวม และวิเคราะห์ฐานข้อมูล 2 ชุด การวิเคราะห์ชุดแรกใช้งานวิจัยแต่ละเรื่องท
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic '517.977.14: 620.1' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography